BACKGROUND: Acute kidney injury (AKI) carries a large burden of morbidity and mortality. Early diagnosis may lead to better strategies of clinical care. Cardiac surgery involving cardiopulmonary bypass is associated with a significant incidence of AKI. The study objective was to determine whether or not preoperative fibroblast growth factor-23 (FGF23) levels differed among pediatric patients who did or did not develop AKI following cardiac surgery. METHODS: A nested case-control study was performed. FGF23 levels were measured pre- and post-operatively in 19 children without chronic kidney disease (CKD) who underwent cardiopulmonary bypass. Five patients developed AKI and 14 patients served as controls. RESULTS: FGF23 levels in patients who developed AKI following cardiac surgery were elevated above normal levels, both pre-operatively and post-operatively compared with those patients who did not develop AKI. Relative risk of developing AKI when the pre-operative FGF23 level was >86 RU/mL was 2.0 (p = 0.033). Preoperative FGF23 levels correlated with post-operative fluid gain (correlation coefficient 0.607, p = 0.0059). CONCLUSIONS: FGF23 may serve as a pre-operative prognostic indicator of the development of AKI following cardiopulmonary bypass surgery in pediatric patients without CKD. Identifying patients more likely to have AKI following surgery provides a means of achieving closer clinical management of AKI and fluid balance.
BACKGROUND:Acute kidney injury (AKI) carries a large burden of morbidity and mortality. Early diagnosis may lead to better strategies of clinical care. Cardiac surgery involving cardiopulmonary bypass is associated with a significant incidence of AKI. The study objective was to determine whether or not preoperative fibroblast growth factor-23 (FGF23) levels differed among pediatric patients who did or did not develop AKI following cardiac surgery. METHODS: A nested case-control study was performed. FGF23 levels were measured pre- and post-operatively in 19 children without chronic kidney disease (CKD) who underwent cardiopulmonary bypass. Five patients developed AKI and 14 patients served as controls. RESULTS:FGF23 levels in patients who developed AKI following cardiac surgery were elevated above normal levels, both pre-operatively and post-operatively compared with those patients who did not develop AKI. Relative risk of developing AKI when the pre-operative FGF23 level was >86 RU/mL was 2.0 (p = 0.033). Preoperative FGF23 levels correlated with post-operative fluid gain (correlation coefficient 0.607, p = 0.0059). CONCLUSIONS:FGF23 may serve as a pre-operative prognostic indicator of the development of AKI following cardiopulmonary bypass surgery in pediatric patients without CKD. Identifying patients more likely to have AKI following surgery provides a means of achieving closer clinical management of AKI and fluid balance.
Authors: David E Leaf; Myles Wolf; Sushrut S Waikar; Herbert Chase; Marta Christov; Serge Cremers; Leonard Stern Journal: Clin J Am Soc Nephrol Date: 2012-06-14 Impact factor: 8.237
Authors: Jordan M Symons; Annabelle N Chua; Michael J G Somers; Michelle A Baum; Timothy E Bunchman; Mark R Benfield; Patrick D Brophy; Douglas Blowey; James D Fortenberry; Deepa Chand; Francisco X Flores; Richard Hackbarth; Steven R Alexander; John Mahan; Kevin D McBryde; Stuart L Goldstein Journal: Clin J Am Soc Nephrol Date: 2007-05-18 Impact factor: 8.237
Authors: Maryann Zhang; Raymond Hsu; Chi-Yuan Hsu; Kristina Kordesch; Erica Nicasio; Alfredo Cortez; Ian McAlpine; Sandra Brady; Hanjing Zhuo; Kirsten N Kangelaris; John Stein; Carolyn S Calfee; Kathleen D Liu Journal: Ann Intensive Care Date: 2011-06-14 Impact factor: 6.925
Authors: Oded Volovelsky; Tara C Terrell; Hayley Swain; Michael R Bennett; David S Cooper; Stuart L Goldstein Journal: Pediatr Nephrol Date: 2018-07-19 Impact factor: 3.714
Authors: Mark R Hanudel; Katherine Wesseling-Perry; Barbara Gales; Georgina Ramos; Vicky Campbell; Kristen Ethridge; Mary Scotti; David A Elashoff; Juan Alejos; Brian Reemtsen; Isidro B Salusky Journal: Pediatr Nephrol Date: 2015-11-02 Impact factor: 3.714